Primordial Genetics launched 10 years ago with the ambition of developing novel genetic technologies that could greatly impact the creation of improved microbes and enzymes for bio-manufacturing, using creative approaches specifically tailored for efficiency gains in biological systems. At a later time, we started focusing our efforts on developing enzymatic production systems for nucleic acids that are used in vaccines and drugs, to enable and support the development of genetic medicines that are revolutionizing drug discovery and will transform healthcare. In the past 10 years, we have made great strides to accomplish these goals. We have built a highly effective team of scientist and business developers who are working hard to advance our vision. We look forward to many more years of building and applying a biotechnology platform that can improve the health and well-being of people, animals and the planet. To paraphrase Motörhead: We are Primordial Genetics – born to kick your ass.
“Utilizing the Human Genome to Expand Microbial Potential with Primordial Genomics,” Covered by DNA Weekly
Team PrimordialAugust 4, 2022